Journal Basic Info

  • Impact Factor: 1.809**
  • H-Index: 6
  • ISSN: 2474-1655
  • DOI: 10.25107/2474-1655
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Epidemiology
  •  Radiology Cases
  •  Orthopedic Sugery
  •  Depression
  •  Tuberculosis
  •  Pneumonia
  •  Cardiology
  •  Neurology

Abstract

Citation: Ann Clin Case Rep. 2023;8(1):2418.DOI: 10.25107/2474-1655.2418

Chylothorax Under Dasatinib in a Child with Chronic Myeloid Leukemia

Xuan F, Zhang B, Zhao X and Wu X*

Department of Children’s Hematologic Oncology Center, The Second Hospital of Hebei Medical University, China

*Correspondance to: Xiaoli Wu 

 PDF  Full Text Case Report | Open Access

Abstract:

A 12-year-old girl was admitted to our hospital for hepatosplenomegaly. She was diagnosed with chronic myeloid leukemia more than 8 years ago. Imatinib was administered orally for 5 years; however, an increase was noted in BCR-ABL1 fusion gene levels and the treatment drug was changed to dasatinib. The BCR-ABL1 fusion gene levels gradually decreased and stabilized; therefore, dasatinib treatment was continued. After 3 years on oral dasatinib therapy, she developed hepatosplenomegaly and chylothorax. After repeated examinations to rule out other causes, dasatinib was discontinued and replaced with nilotinib. Thereafter, the pleural effusion completely resolved, the liver and spleen size normalized and the primary disease was controlled and stabilized.

Keywords:

Chronic myeloid leukemia; Dasatinib; Chylothorax; Children

Cite the Article:

Xuan F, Zhang B, Zhao X, Wu X. Chylothorax Under Dasatinib in a Child with Chronic Myeloid Leukemia. Ann Clin Case Rep. 2023; 8: 2418.

Search Our Journal

Journal Indexed In

Articles in PubMed

Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and other Naturally Occurring Compounds, Part I
 PubMed  PMC  PDF  Full Text
Tocotrienols: Exciting Biological and Pharmacological Properties of Tocotrienols and Naturally Occurring Compounds, Part II
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Traditional Chinese Patent Medicine Qizhijiangtang Capsule for Non-Proliferative Diabetic Retinopathy: Study Protocol for a Randomized Controlled Trial
 Abstract  PDF  Full Text
LncRNA SNHG1 Alleviates the IL-1β-Induced Chondrocytes Inflammatory Injury via Targeting miR-143- 3p/KLF2 Axis
 Abstract  PDF  Full Text
View More...